PDB Short entry for 2XPG HEADER IMMUNE SYSTEM 26-AUG-10 2XPG TITLE CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HEAVY CHAIN, RESIDUES 25-298; COMPND 5 SYNONYM: HLA-A3, MHC CLASS I ANTIGEN A*3; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: BETA2-MICROGLOBULIN FORM PI 5.3, RESIDUES 22-118; COMPND 11 SYNONYM: HLA-A3; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: MYELIN PROTEOLIPID PROTEIN; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: RESIDUES 45-53; COMPND 17 SYNONYM: PLP PEPTIDE, PLP, LIPOPHILIN; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BLR (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-22B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BLR (DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET-22B; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606 KEYWDS IMMUNE SYSTEM, AUTOIMMUNITY, MULTIPLE SCLEROSIS EXPDTA X-RAY DIFFRACTION AUTHOR R.M.MCMAHON,L.FRIIS,C.SIEBOLD,M.A.FRIESE,L.FUGGER,E.Y.JONES REVDAT 3 20-DEC-23 2XPG 1 REMARK REVDAT 2 28-MAR-12 2XPG 1 JRNL REMARK VERSN REVDAT 1 27-APR-11 2XPG 0 JRNL AUTH R.M.MCMAHON,L.FRIIS,C.SIEBOLD,M.A.FRIESE,L.FUGGER,E.Y.JONES JRNL TITL STRUCTURE OF HLA-A0301 IN COMPLEX WITH A PEPTIDE OF JRNL TITL 2 PROTEOLIPID PROTEIN: INSIGHTS INTO THE ROLE OF HLA-A ALLELES JRNL TITL 3 IN SUSCEPTIBILITY TO MULTIPLE SCLEROSIS JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 67 447 2011 JRNL REFN ISSN 0907-4449 JRNL PMID 21543847 JRNL DOI 10.1107/S0907444911007888 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13957 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.7513 - 4.4325 1.00 2796 124 0.1689 0.1987 REMARK 3 2 4.4325 - 3.5247 1.00 2645 150 0.1638 0.2109 REMARK 3 3 3.5247 - 3.0811 1.00 2614 157 0.1934 0.2749 REMARK 3 4 3.0811 - 2.8002 1.00 2586 146 0.2342 0.3101 REMARK 3 5 2.8002 - 2.6000 1.00 2622 117 0.2728 0.3677 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.60 REMARK 3 SHRINKAGE RADIUS : 0.27 REMARK 3 K_SOL : 0.41 REMARK 3 B_SOL : 41.30 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.86840 REMARK 3 B22 (A**2) : 8.95220 REMARK 3 B33 (A**2) : -2.08380 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3195 REMARK 3 ANGLE : 0.718 4330 REMARK 3 CHIRALITY : 0.053 443 REMARK 3 PLANARITY : 0.003 569 REMARK 3 DIHEDRAL : 14.052 1170 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESID 1:181) REMARK 3 ORIGIN FOR THE GROUP (A): 11.2798 -4.5660 -11.3491 REMARK 3 T TENSOR REMARK 3 T11: 0.0379 T22: 0.0552 REMARK 3 T33: -0.0059 T12: 0.0248 REMARK 3 T13: -0.0009 T23: 0.0002 REMARK 3 L TENSOR REMARK 3 L11: 0.4083 L22: 1.0286 REMARK 3 L33: 0.1774 L12: 0.1217 REMARK 3 L13: 0.2125 L23: -0.1727 REMARK 3 S TENSOR REMARK 3 S11: -0.0221 S12: -0.0337 S13: -0.0755 REMARK 3 S21: 0.0903 S22: 0.0391 S23: -0.0051 REMARK 3 S31: -0.0663 S32: -0.1380 S33: -0.0084 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESID 182:274) REMARK 3 ORIGIN FOR THE GROUP (A): 43.5927 -10.9477 -23.5697 REMARK 3 T TENSOR REMARK 3 T11: 0.0788 T22: 0.0910 REMARK 3 T33: 0.1727 T12: -0.0102 REMARK 3 T13: 0.0150 T23: -0.0042 REMARK 3 L TENSOR REMARK 3 L11: 0.3374 L22: 0.0962 REMARK 3 L33: 0.3904 L12: -0.1351 REMARK 3 L13: -0.0055 L23: -0.1102 REMARK 3 S TENSOR REMARK 3 S11: 0.0151 S12: -0.0462 S13: 0.1896 REMARK 3 S21: 0.0107 S22: -0.0617 S23: -0.0916 REMARK 3 S31: -0.0300 S32: 0.0214 S33: 0.0409 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN B AND (RESID 2:98) REMARK 3 ORIGIN FOR THE GROUP (A): 23.6352 -10.1987 -34.8551 REMARK 3 T TENSOR REMARK 3 T11: 0.0704 T22: 0.0467 REMARK 3 T33: 0.0158 T12: 0.0417 REMARK 3 T13: -0.0058 T23: 0.0033 REMARK 3 L TENSOR REMARK 3 L11: 0.4121 L22: 0.4754 REMARK 3 L33: 0.2862 L12: -0.3398 REMARK 3 L13: 0.1833 L23: -0.1296 REMARK 3 S TENSOR REMARK 3 S11: 0.1344 S12: 0.0235 S13: -0.0203 REMARK 3 S21: -0.1264 S22: -0.0776 S23: 0.0342 REMARK 3 S31: -0.0564 S32: -0.0327 S33: -0.0293 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN C AND (RESID 1:9) REMARK 3 ORIGIN FOR THE GROUP (A): 5.0371 -3.0578 -6.7923 REMARK 3 T TENSOR REMARK 3 T11: 0.2356 T22: 0.2333 REMARK 3 T33: 0.1797 T12: 0.0926 REMARK 3 T13: -0.0845 T23: 0.0044 REMARK 3 L TENSOR REMARK 3 L11: 0.2195 L22: 0.5578 REMARK 3 L33: 0.1712 L12: -0.3300 REMARK 3 L13: 0.1673 L23: -0.3030 REMARK 3 S TENSOR REMARK 3 S11: -0.1554 S12: -0.2034 S13: 0.0141 REMARK 3 S21: 0.1484 S22: 0.1651 S23: -0.0266 REMARK 3 S31: -0.0838 S32: -0.0871 S33: -0.0083 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XPG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1290045177. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9699 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14030 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1DUZ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS-PROPANE, PH 8.0, 0.2 M REMARK 280 NA/K PHOSPHATE, 20% (V/V) PEG3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.07000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.60500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.77500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.60500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.07000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.77500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 232 CG CD OE1 OE2 REMARK 470 GLU A 264 CG CD OE1 OE2 REMARK 470 LYS B 58 CG CD CE NZ REMARK 470 GLU B 69 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -119.87 62.22 REMARK 500 LEU A 110 -57.86 -123.40 REMARK 500 ARG A 114 111.85 -164.25 REMARK 500 TYR A 123 -70.12 -114.69 REMARK 500 SER A 195 -153.44 -144.09 REMARK 500 ASP A 220 18.39 57.96 REMARK 500 TRP B 60 -3.58 81.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 2XKS RELATED DB: PDB REMARK 900 PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B *3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN- BARR VIRUS REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-B(ASTERISK )2705 REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 2VLK RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA- A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA -AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA- A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 (HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 2X89 RELATED DB: PDB REMARK 900 STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 2X4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE REMARK 900 RT468-476 REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C- TERMINUS REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 (HLA-A2 .1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 2X4O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE REMARK 900 PEPTIDE ENV120-128 REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 2X4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2VLR RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BVO RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG- REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75-82) OF HIV1 REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/ HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 (LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 2XKU RELATED DB: PDB REMARK 900 PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 2J8U RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 2X4T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE- REMARK 900 CLEAVABLE PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ONHLA-B AND-C REMARK 900 MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2- MICROGLOBULIN REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209 -T2M) REMARK 900 BOUND TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2(TAFTIPSI) REMARK 900 RELATED ID: 2BVP RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG- REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3- INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2X4R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS REMARK 900 (CMV) PP65 EPITOPE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA- ASSOCIATEDANTIGEN 3 (RESIDUES REMARK 900 271-279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF-RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE ( TAX), AND REMARK 900 HLA-A 0201 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14- MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B*3501 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE (RESIDUES 412-420) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2X70 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/ MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2 -MICROGLOBULIN REMARK 900 AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF-RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN- BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 2X4N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL REMARK 900 FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT REMARK 900 TREATMENT REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX REMARK 900 RELATED ID: 2VLL RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2-MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 2VLJ RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2X4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REMARK 900 REPRESENTING THE EPITOPE OF THE H5N1 ( AVIAN FLU) NUCLEOPROTEIN REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C- TERMINUS REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG- REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. DBREF 2XPG A 1 274 UNP P04439 1A03_HUMAN 25 298 DBREF 2XPG B 2 98 UNP P61769 B2MG_HUMAN 22 118 DBREF 2XPG C 1 9 UNP P60201 MYPR_HUMAN 45 53 SEQADV 2XPG ALA B 1 UNP P61769 EXPRESSION TAG SEQRES 1 A 274 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 274 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 274 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 274 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 274 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLN GLU THR ARG SEQRES 6 A 274 ASN VAL LYS ALA GLN SER GLN THR ASP ARG VAL ASP LEU SEQRES 7 A 274 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 274 SER HIS THR ILE GLN ILE MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 274 SER ASP GLY ARG PHE LEU ARG GLY TYR ARG GLN ASP ALA SEQRES 10 A 274 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 274 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN ILE THR SEQRES 12 A 274 LYS ARG LYS TRP GLU ALA ALA HIS GLU ALA GLU GLN LEU SEQRES 13 A 274 ARG ALA TYR LEU ASP GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 274 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 274 ASP PRO PRO LYS THR HIS MET THR HIS HIS PRO ILE SER SEQRES 16 A 274 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 274 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 274 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 274 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 274 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 274 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 274 TRP SEQRES 1 B 98 ALA GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 98 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 98 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 98 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 98 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 98 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 98 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 98 ILE VAL LYS TRP ASP ARG ASP SEQRES 1 C 9 LYS LEU ILE GLU THR TYR PHE SER LYS FORMUL 4 HOH *16(H2 O) HELIX 1 1 PRO A 50 GLU A 55 5 6 HELIX 2 2 GLY A 56 ASN A 86 1 31 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 ASP A 161 1 11 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLU A 253 GLN A 255 5 3 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O ILE A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 PRO A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 ARG A 234 PRO A 235 1 O ARG A 234 N GLN A 242 SHEET 1 AC 4 LYS A 186 PRO A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 THR A 228 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AD 2 ARG A 234 PRO A 235 0 SHEET 2 AD 2 PHE A 241 PRO A 250 1 O GLN A 242 N ARG A 234 SHEET 1 AE 4 GLU A 222 ASP A 223 0 SHEET 2 AE 4 THR A 214 ARG A 219 -1 O ARG A 219 N GLU A 222 SHEET 3 AE 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AE 4 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 SER B 55 PHE B 56 1 O SER B 55 N TYR B 63 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BC 2 SER B 55 PHE B 56 0 SHEET 2 BC 2 PHE B 62 PHE B 70 1 O TYR B 63 N SER B 55 SHEET 1 BD 4 GLU B 44 ARG B 45 0 SHEET 2 BD 4 ILE B 35 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BD 4 TYR B 78 HIS B 84 -1 O ALA B 79 N LEU B 40 SHEET 4 BD 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 CISPEP 1 PRO A 15 GLY A 16 0 -2.91 CISPEP 2 TYR A 209 PRO A 210 0 0.61 CISPEP 3 SER A 251 GLY A 252 0 0.52 CISPEP 4 HIS B 31 PRO B 32 0 7.70 CRYST1 62.140 65.550 107.210 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016093 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009327 0.00000